Nuclear factor-κB activation by transforming growth factor-β1 drives tumour microenvironment-mediated drug resistance in neuroblastoma.
Kévin LouaultLaurence BlavierMen-Hua LeeRebekah J KennedyG Esteban FernandezBruce R PawelShahab AsgharzadehYves A DeClerckPublished in: British journal of cancer (2024)
The data provides a novel insight into a targetable mechanism of environment-mediated drug resistance.